Possible clinical indications of ceftobiprole

Area of Science:

• Infectious Diseases
• Pharmacology
• Microbiology

Background:

• Ceftobiprole is a fifth-generation cephalosporin antibiotic.
• It is currently approved for community-acquired pneumonia and hospital-acquired pneumonia.
• Its microbiological and pharmacokinetic properties suggest broader therapeutic potential.

Purpose of the Study:

• To explore the potential of ceftobiprole as empirical monotherapy for additional infections.
• To identify specific clinical scenarios where ceftobiprole could be utilized beyond its current indications.

Main Methods:

• Review of microbiological data and pharmacokinetic profiles of ceftobiprole.
• Analysis of clinical scenarios for potential application of ceftobiprole monotherapy.

Main Results:

• Ceftobiprole exhibits attractive microbiological and pharmacokinetic characteristics.
• Potential applications include complicated skin and soft tissue infections.
• It may be suitable for moderate-severe diabetic foot infections (without bone involvement).
• Considered for vascular-catheter-associated bloodstream infections.
• Evaluated for fever of unknown origin in hospitalized patients (excluding septic shock/profound immunosuppression).

Conclusions:

• Ceftobiprole's profile supports its consideration for empirical monotherapy in several challenging infection types.
• Further clinical evaluation is warranted for these expanded indications.